fulgentgenetics.com (FLGT) Cash Funds per Single Share

Fulgent Genetics, Inc. (FLGT) relies on US domestic demand while remaining sensitive to reagent supply chain disruptions. The development of AI algorithms and spatial biology is driving R&D. The cash per share on the GURU.Markets service time chart shows that the current value is 10.50. Liquidity is maintained through close cooperation with government laboratories and clinics.
Comprehensive metric breakdowns and analytics for Fulgent (FLGT)

For Fulgent Genetics, Inc. (FLGT), with its focus on NGS sequencing and oncology diagnostics, the cash per share analysis confirms a significant reserve for M&A transactions amounting to 10.50. This metric objectively measures the equity value of liquidity, allowing for the immediate identification of cash gaps and an assessment of the business's real margin of safety in the event of a potential decline in operating profit.